| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 1 | - | - | - | - | 12.2 | 71.8 | 2,090.4 | 2,073.7 | 4,254.1 |
| 3 | 1 | - | 1 | - | 1 | 0.7 | 9.4 | 306.6 | 271.1 | 593.8 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 7.5 | 7.5 |
| - | - | - | - | - | - | 1.5 | 1.5 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 59,310 | 99.2% | -2.85 | 8,220 | 99.2% |
| Optic-unspecified(L) | 445 | 0.7% | -2.80 | 64 | 0.8% |
| LO(L) | 15 | 0.0% | -2.32 | 3 | 0.0% |
| upstream partner | # | NT | conns Pm7 | % In | CV |
|---|---|---|---|---|---|
| Tm2 (L) | 883 | ACh | 1,667.1 | 40.1% | 0.3 |
| Tm3 (L) | 1015 | ACh | 1,645.9 | 39.6% | 0.4 |
| Pm3 (L) | 33 | GABA | 266 | 6.4% | 0.3 |
| TmY14 (L) | 243 | unc | 184.5 | 4.4% | 0.4 |
| MeLo14 (L) | 19 | Glu | 134.1 | 3.2% | 0.5 |
| MeVPOL1 (R) | 1 | ACh | 35.4 | 0.9% | 0.0 |
| Mi1 (L) | 231 | ACh | 27.1 | 0.7% | 0.8 |
| Pm10 (L) | 37 | GABA | 25.2 | 0.6% | 0.5 |
| Mi4 (L) | 192 | GABA | 20.5 | 0.5% | 0.7 |
| MeVC12 (R) | 1 | ACh | 17.2 | 0.4% | 0.0 |
| TmY5a (L) | 148 | Glu | 13.5 | 0.3% | 0.4 |
| Pm11 (L) | 2 | GABA | 13.2 | 0.3% | 0.1 |
| TmY3 (L) | 100 | ACh | 12.6 | 0.3% | 0.7 |
| MeLo9 (L) | 38 | Glu | 9.7 | 0.2% | 0.5 |
| T2 (L) | 80 | ACh | 7.7 | 0.2% | 0.7 |
| Mi9 (L) | 62 | Glu | 7.5 | 0.2% | 0.5 |
| Mi10 (L) | 46 | ACh | 6.8 | 0.2% | 0.6 |
| Pm1 (L) | 57 | GABA | 5.9 | 0.1% | 0.5 |
| OLVC3 (R) | 1 | ACh | 5.1 | 0.1% | 0.0 |
| Pm7 (L) | 14 | GABA | 4.5 | 0.1% | 0.5 |
| MeLo11 (L) | 12 | Glu | 4.1 | 0.1% | 0.9 |
| OA-AL2i2 (L) | 2 | OA | 3.1 | 0.1% | 0.2 |
| MeVPOL1 (L) | 1 | ACh | 2.8 | 0.1% | 0.0 |
| MeVC25 (L) | 1 | Glu | 2.6 | 0.1% | 0.0 |
| Tm4 (L) | 23 | ACh | 2.4 | 0.1% | 0.4 |
| TmY19a (L) | 13 | GABA | 2 | 0.0% | 0.7 |
| MeLo8 (L) | 9 | GABA | 1.7 | 0.0% | 1.5 |
| Mi19 (L) | 5 | unc | 1.5 | 0.0% | 0.8 |
| TmY18 (L) | 17 | ACh | 1.5 | 0.0% | 0.6 |
| T3 (L) | 9 | ACh | 1.4 | 0.0% | 0.7 |
| Pm4 (L) | 13 | GABA | 1.4 | 0.0% | 0.6 |
| Pm2a (L) | 16 | GABA | 1.4 | 0.0% | 0.4 |
| Am1 (L) | 1 | GABA | 1.1 | 0.0% | 0.0 |
| T4b (L) | 14 | ACh | 1.1 | 0.0% | 0.2 |
| T2a (L) | 15 | ACh | 1.1 | 0.0% | 0.0 |
| Tm1 (L) | 11 | ACh | 1 | 0.0% | 0.3 |
| C3 (L) | 13 | GABA | 1 | 0.0% | 0.2 |
| OA-AL2i1 (L) | 1 | unc | 0.7 | 0.0% | 0.0 |
| Pm5 (L) | 9 | GABA | 0.7 | 0.0% | 0.3 |
| Pm6 (L) | 5 | GABA | 0.6 | 0.0% | 0.6 |
| TmY15 (L) | 6 | GABA | 0.6 | 0.0% | 0.5 |
| Mi2 (L) | 7 | Glu | 0.6 | 0.0% | 0.4 |
| Tm12 (L) | 6 | ACh | 0.6 | 0.0% | 0.5 |
| MeLo13 (L) | 6 | Glu | 0.6 | 0.0% | 0.5 |
| Mi13 (L) | 9 | Glu | 0.6 | 0.0% | 0.0 |
| ME_unclear (L) | 1 | Glu | 0.6 | 0.0% | 0.0 |
| TmY10 (L) | 7 | ACh | 0.6 | 0.0% | 0.3 |
| Pm2b (L) | 8 | GABA | 0.6 | 0.0% | 0.0 |
| Tm16 (L) | 1 | ACh | 0.4 | 0.0% | 0.0 |
| Y11 (L) | 3 | Glu | 0.4 | 0.0% | 0.7 |
| DNc02 (R) | 1 | unc | 0.4 | 0.0% | 0.0 |
| T4c (L) | 4 | ACh | 0.4 | 0.0% | 0.3 |
| Pm8 (L) | 4 | GABA | 0.4 | 0.0% | 0.3 |
| TmY19b (L) | 5 | GABA | 0.4 | 0.0% | 0.0 |
| MeLo1 (L) | 2 | ACh | 0.3 | 0.0% | 0.5 |
| Y14 (L) | 3 | Glu | 0.3 | 0.0% | 0.4 |
| DNp30 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm6 (L) | 3 | ACh | 0.3 | 0.0% | 0.4 |
| Y3 (L) | 2 | ACh | 0.3 | 0.0% | 0.5 |
| T4d (L) | 3 | ACh | 0.2 | 0.0% | 0.0 |
| Dm14 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| T4_unclear (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPLp1 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVC26 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY9a (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| TmY17 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| MeVC1 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY4 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPLp2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| CT1 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm20 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| T4a (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| Y12 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY13 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| L4 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi14 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPLo1 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| C2 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| TmY9b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Lawf2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ME_LO_unclear (L) | 1 | unc | 0.1 | 0.0% | 0.0 |
| MeVP53 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu3c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeLo10 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| TmY21 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| LC14b (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Pm7 | % Out | CV |
|---|---|---|---|---|---|
| Tm2 (L) | 881 | ACh | 457.7 | 26.8% | 0.4 |
| T2 (L) | 806 | ACh | 370 | 21.6% | 0.4 |
| Pm3 (L) | 33 | GABA | 243.4 | 14.2% | 0.2 |
| Tm3 (L) | 904 | ACh | 160.6 | 9.4% | 0.6 |
| TmY5a (L) | 606 | Glu | 120.9 | 7.1% | 0.6 |
| TmY14 (L) | 240 | unc | 97.6 | 5.7% | 0.6 |
| MeLo13 (L) | 36 | Glu | 28.2 | 1.6% | 0.5 |
| Tm6 (L) | 199 | ACh | 19.7 | 1.2% | 0.5 |
| TmY19a (L) | 39 | GABA | 19.2 | 1.1% | 0.8 |
| Lawf2 (L) | 122 | ACh | 18.6 | 1.1% | 0.7 |
| TmY15 (L) | 71 | GABA | 16.2 | 0.9% | 1.0 |
| Pm10 (L) | 34 | GABA | 12.9 | 0.8% | 0.5 |
| TmY3 (L) | 120 | ACh | 11.5 | 0.7% | 0.4 |
| TmY19b (L) | 15 | GABA | 8.8 | 0.5% | 0.8 |
| Pm11 (L) | 2 | GABA | 8.6 | 0.5% | 0.2 |
| Am1 (L) | 1 | GABA | 8.5 | 0.5% | 0.0 |
| MeLo14 (L) | 19 | Glu | 8.1 | 0.5% | 0.8 |
| Mi1 (L) | 66 | ACh | 5.9 | 0.3% | 0.6 |
| T3 (L) | 59 | ACh | 5.6 | 0.3% | 0.7 |
| Pm1 (L) | 57 | GABA | 5.4 | 0.3% | 0.5 |
| T4b (L) | 69 | ACh | 5.4 | 0.3% | 0.3 |
| Tm12 (L) | 58 | ACh | 5.1 | 0.3% | 0.8 |
| Pm7 (L) | 14 | GABA | 4.5 | 0.3% | 0.5 |
| MeVP60 (L) | 1 | Glu | 4.4 | 0.3% | 0.0 |
| TmY18 (L) | 53 | ACh | 4.1 | 0.2% | 0.3 |
| MeVP24 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| Mi13 (L) | 48 | Glu | 3.9 | 0.2% | 0.3 |
| C3 (L) | 45 | GABA | 3.4 | 0.2% | 0.2 |
| Tm4 (L) | 45 | ACh | 3.2 | 0.2% | 0.0 |
| Tm26 (L) | 19 | ACh | 2.7 | 0.2% | 0.7 |
| Pm4 (L) | 24 | GABA | 2.4 | 0.1% | 0.9 |
| T2a (L) | 30 | ACh | 2.4 | 0.1% | 0.4 |
| Y3 (L) | 20 | ACh | 2.3 | 0.1% | 0.9 |
| C2 (L) | 26 | GABA | 2.1 | 0.1% | 0.4 |
| Pm13 (L) | 1 | Glu | 1.9 | 0.1% | 0.0 |
| MeVPMe1 (L) | 5 | Glu | 1.8 | 0.1% | 0.8 |
| MeVP4 (L) | 14 | ACh | 1.7 | 0.1% | 0.6 |
| MeLo9 (L) | 14 | Glu | 1.7 | 0.1% | 0.6 |
| TmY21 (L) | 15 | ACh | 1.5 | 0.1% | 0.5 |
| MeLo8 (L) | 10 | GABA | 1.4 | 0.1% | 0.6 |
| Y14 (L) | 16 | Glu | 1.4 | 0.1% | 0.4 |
| Tm9 (L) | 17 | ACh | 1.3 | 0.1% | 0.2 |
| Mi14 (L) | 13 | Glu | 1.3 | 0.1% | 0.4 |
| ME_unclear (L) | 2 | Glu | 1.2 | 0.1% | 0.6 |
| Tm1 (L) | 14 | ACh | 1.2 | 0.1% | 0.3 |
| Pm5 (L) | 12 | GABA | 1.2 | 0.1% | 0.5 |
| MeLo7 (L) | 9 | ACh | 0.9 | 0.1% | 0.4 |
| TmY13 (L) | 12 | ACh | 0.9 | 0.1% | 0.0 |
| ME_LO_unclear (L) | 1 | unc | 0.7 | 0.0% | 0.0 |
| MeVP3 (L) | 6 | ACh | 0.7 | 0.0% | 0.4 |
| MeVPMe2 (L) | 5 | Glu | 0.7 | 0.0% | 0.4 |
| T4a (L) | 9 | ACh | 0.7 | 0.0% | 0.3 |
| TmY16 (L) | 10 | Glu | 0.7 | 0.0% | 0.0 |
| Pm2a (L) | 8 | GABA | 0.6 | 0.0% | 0.0 |
| OA-AL2i2 (L) | 2 | OA | 0.5 | 0.0% | 0.4 |
| Mi9 (L) | 7 | Glu | 0.5 | 0.0% | 0.0 |
| Mi19 (L) | 3 | unc | 0.4 | 0.0% | 0.4 |
| T4c (L) | 6 | ACh | 0.4 | 0.0% | 0.0 |
| TmY4 (L) | 6 | ACh | 0.4 | 0.0% | 0.0 |
| Pm8 (L) | 5 | GABA | 0.4 | 0.0% | 0.0 |
| Pm6 (L) | 3 | GABA | 0.3 | 0.0% | 0.4 |
| Tm37 (L) | 3 | Glu | 0.3 | 0.0% | 0.4 |
| Pm2b (L) | 3 | GABA | 0.3 | 0.0% | 0.4 |
| MeLo1 (L) | 3 | ACh | 0.3 | 0.0% | 0.4 |
| MeLo11 (L) | 2 | Glu | 0.3 | 0.0% | 0.0 |
| MeVC12 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| MeVC25 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| Tm20 (L) | 4 | ACh | 0.3 | 0.0% | 0.0 |
| Tm5a (L) | 4 | ACh | 0.3 | 0.0% | 0.0 |
| Y11 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| L5 (L) | 2 | ACh | 0.2 | 0.0% | 0.3 |
| Tm5Y (L) | 3 | ACh | 0.2 | 0.0% | 0.0 |
| Tlp13 (L) | 3 | Glu | 0.2 | 0.0% | 0.0 |
| Tm16 (L) | 3 | ACh | 0.2 | 0.0% | 0.0 |
| Tm5c (L) | 3 | Glu | 0.2 | 0.0% | 0.0 |
| T4d (L) | 3 | ACh | 0.2 | 0.0% | 0.0 |
| MeVPOL1 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Tm23 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| OLVC3 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPOL1 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm38 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| MeVP18 (L) | 2 | Glu | 0.1 | 0.0% | 0.0 |
| Mi10 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| DNp30 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm29 (L) | 2 | Glu | 0.1 | 0.0% | 0.0 |
| MeTu2a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVC11 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY9a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CT1 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeVP17 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVPLp2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Dm18 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| MeTu3c (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm24 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeVPLp1 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| LOP_ME_unclear (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeLo12 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeLo10 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Pm9 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| Y12 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| LC12 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| MeTu4e (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY_unclear (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi20 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| OA-AL2i1 (L) | 1 | unc | 0.1 | 0.0% | 0.0 |
| TmY9b (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm39 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Mi2 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| MeVP23 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Y13 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| Tm36 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| Tm31 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |